![Carrie Bourdow](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Carrie Bourdow
Algemeen Directeur bij
TREVENA, INC.
Profiel
Carrie L.
Bourdow is currently the Chairman & Chief Executive Officer at Trevena, Inc. She previously served as an Independent Director at Sesen Bio, Inc. from 2020 to 2023 and at Nabriva Therapeutics Plc from 2017 to 2023.
Prior to that, she was the Vice President-Marketing at Cubist Pharmaceuticals LLC from 2013 to 2015.
Ms. Bourdow holds an undergraduate degree from Hendrix College and an MBA from Southern Illinois University.
Actieve functies van Carrie Bourdow
| Bedrijven | Functie | Begin |
|---|---|---|
| TREVENA, INC. | Algemeen Directeur | 01-10-2018 |
Eerdere bekende functies van Carrie Bourdow
| Bedrijven | Functie | Einde |
|---|---|---|
| NABRIVA THERAPEUTICS PLC | Directeur/Bestuurslid | 30-07-2023 |
| CARISMA THERAPEUTICS, INC. | Directeur/Bestuurslid | 07-03-2023 |
| CUBIST PHARMACEUTICALS INC | Verkoop & Marketing | 01-05-2015 |
Opleiding van Carrie Bourdow
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
48
Eerstegraads connecties
6
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 6 |
|---|---|
Cubist Pharmaceuticals LLC
 Cubist Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Engages in research, development and commercialization of pharmaceutical products | Health Technology |
Hendrix College
 Hendrix College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Southern Illinois University
 Southern Illinois University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Trevena, Inc.
 Trevena, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company focused on the development and commercialization of novel medicines for patients affected by central nervous system | Health Technology |
Sesen Bio, Inc.
 Sesen Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops protein therapeutics to treat eye diseases | Health Technology |
Nabriva Therapeutics Plc
 Nabriva Therapeutics Plc Pharmaceuticals: MajorHealth Technology Engages in the research, development, and commercialization of novel anti-infective agents | Health Technology |
Kies MarketScreener 
